tiprankstipranks
Inhibikase Therapeutics (IKT)
NASDAQ:IKT

Inhibikase Therapeutics (IKT) Market Cap & Net Worth

377 Followers

Inhibikase Therapeutics Market Cap

Inhibikase Therapeutics has a market cap or net worth of $229.74M as of Apr 09, 2026. Its market cap has increase by 63.51% in one year.
Market Cap
$229.74M
Enterprise Value
-$15.68M
1-Year Change
63.51%
Category
Micro (Under 300M)
Stock Price
$1.76

Market Cap Chart

Market Cap History
Date
Market Cap
% Change
Apr 07, 2026
124.97M-1.68%
Apr 06, 2026
127.10M-0.56%
Apr 02, 2026
127.81M-0.55%
Apr 01, 2026
128.52M+7.74%
Mar 31, 2026
119.28M+6.33%
Mar 30, 2026
112.18M-5.95%
Mar 27, 2026
119.28M+3.07%
Mar 26, 2026
115.73M0.00%
Mar 25, 2026
115.73M+1.87%
Mar 24, 2026
113.60M-8.05%